Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ - Archive ouverte HAL Access content directly
Journal Articles Journal of the European Academy of Dermatology and Venereology Year : 2020

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ

M. Masson Regnault
J. Castañeda‐sanabria
  • Function : Author
M.H.T. Diep Tran
  • Function : Author
M. Beylot‐barry
H. Bachelez
N. Beneton
  • Function : Author
O. Chosidow
A. Dupuy
  • Function : Author
P. Joly
  • Function : Author
D. Jullien
  • Function : Author
E. Mahé
M.‐a. Richard
  • Function : Author
F. Tubach
E. Sbidian
C. Paul
Not file

Dates and versions

hal-03434494 , version 1 (18-11-2021)

Identifiers

Cite

M. Masson Regnault, J. Castañeda‐sanabria, M.H.T. Diep Tran, M. Beylot‐barry, H. Bachelez, et al.. Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ. Journal of the European Academy of Dermatology and Venereology, 2020, 34 (2), pp.293-300. ⟨10.1111/jdv.15878⟩. ⟨hal-03434494⟩
8 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More